The complementary role of ducocorticosteroids and long-acting β-adrenergic agonists

Allergy: European Journal of Allergy and Clinical Immunology

Volumn 53, Issue SUPPL. 42, 1998, Pages 7-13

  Chung, K F ^a  

^a NATIONAL HEART AND LUNG INSTITUTE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

BECLOMETASONE DIPROPIONATE; BETA ADRENERGIC RECEPTOR STIMULATING AGENT; BUDESONIDE; DEXAMETHASONE; FENOTEROL; GLUCOCORTICOID; INTERLEUKIN 1BETA; ISOPRENALINE; SALBUTAMOL; SALMETEROL; TERBUTALINE;

ASTHMA; BETA ADRENERGIC STIMULATION; CLINICAL TRIAL; CONFERENCE PAPER; CORTICOSTEROID THERAPY; DOSE TIME EFFECT RELATION; DRUG EFFICACY; DRUG POTENTIATION; HUMAN; INHALATIONAL DRUG ADMINISTRATION; NONHUMAN; PRIORITY JOURNAL; RAT;

ADRENERGIC BETA-AGONISTS; ANIMALS; ANTI-ASTHMATIC AGENTS; ASTHMA; DRUG THERAPY, COMBINATION; GLUCOCORTICOIDS; HUMANS; TIME FACTORS;

EID: 0031945819     PISSN: 01054538     EISSN: 13989995     Source Type: Journal    
DOI: 10.1111/j.1398-9995.1998.tb04887.x     Document Type: Article

References (30)

1. Auerbach I, Springer C, Godfrey S. Total population survey of the frequency and severity of asthma in 17 year old boys in an urban area in Israel. Thorax 1993;48:139-41.
2. Crain EF, Weiss KB, Bijur PE, Hersh M, Westbrook L, Stein RE. An estimate of the prevalence of asthma and wheezing among inner-city children. Pediatrics 1994;94: 356-62.
3. National Asthma Education Program. Executive summary: guidelines for the diagnosis and management of asthma. Bethesda, MD: National Institutes of Health, 1994. Publication no. 94-3042A.
4. Guidelines for the management of asthma: a summary. BMJ 1993;306:776-82
5. British Thoracic Society guidelines on asthma management. Thorax 1993;48:Sl-S24.
6. Chung KF. The current debate about P,-adrenergic agonists. J R SOC Med 1993;86:96-100.
7. Crane J, Pearce N, Flatt A, et al. Prescribed fenoterol and death from asthma in New Zealand, 1981-83: case control study. Lancet 1989;1:917-22.
8. Kerrebijn KF, van Essen-Zandvliet EE, Neijens HJ. Effect of long-term treatment with inhaled corticosteroids and beta-agonists on the bronchial responsiveness in children with asthma. J Allergy Clin Immunol 1987;79:653-9
9. Sears MR, Taylor DR, Print CG, et al. Regular inhaled beta-agonist treatment in bronchial asthma. Lancet 1990;336:1391-6
10. Drazen JM, Israel E, Boushey HA, et al. Comparison of regularly scheduled with as-needed use of albuterol in mild asthma. N Engl J Med 1996;335:841-7.
11. Chapman KR, Keston S, Szalai JP. Regular vs. as-needed inhaled salbutamol in asthma control. Lancet 1994;343: 1379-82
12. Wilding PJ, Clark MM, Obome J, Bennett JA, Tattersfield AE. Effect of regular terbutaline on the airway response to inhaled budesonide. Thorax 1996;51:989-92.
13. Lofdahl CG, Chung KF. Long-acting P,-adrenoceptor agonists: a new perspective in the treatment of asthma. Eur Respir J 1991;4:218-26.
14. Greening AP, Ind PW, Northfield M, Shaw G. Added salmeterol versus higher dose corticosteroid in asthma patients with symptoms on existing inhaled corticosteroid. Lancet 1994;344:219-24.
15. Woolcock A, Lundback B, Ringdal N, Jacques LA. Comparison of addition of salmeterol to inhaled steroids with doubling of the dose of inhaled steroids. Am J Respir Crit Care Med 1996;153:1481-8.
16. Wilding PJ, Clark MM, Thompson Coon J, et al. Effect of long term treatment with salmeterol on asthma control: a double blind, randomised cross-over study. BMJ 1997;314: 1441-6.
17. Szentivanyi A. The P-adrenergic theory of the atopic abnormality in bronchial asthma. J Allergy 1968;452:203-32.
18. Spina D, Rigby RJ, Paterson JW, Goldie RG. Autoradiographic localisation of P-adrenergic receptors in asthmatic human lung. Am Rev Respir Dis 1989;140:1410-15.
19. Bai TR, Zhou D, Aubert J, Lizee D, Hayashi S, Bondy GI? Expression of P,-adrenergic receptor mRNA in peripheral lung in asthma and chronic obstructive pulmonary disease. Am J Respir Cell Mol Biol 1993;8:325-33.
20. Koto H, Mak JCW, Haddad EB, et al. Mechanisms of impaired P-adrenergic receptor relaxation by IL-p in viva J Clin Invest 1996;98:1780-9.
21. Mak JC, Nishikawa M, Barnes PJ. Glucocorticosteroids increase P,-adrenergic receptor transcription in human lung. Am J Physiol 1995;268:L41-6.
22. Mak JC, Nishikawa M, Shirasaki H, Miyayasu K, Barnes PJ. Protective effect of a glucocorticoid on down-regulation of pulmonary P,-adrenergic receptors in viva J Clin Invest 1995;96:99-106.
23. Yates DH, Sussman HS, Shaw MJ, Barnes PJ, Chung KF. Regular formoterol treatment in mild asthma: effect on bronchial responsiveness during and after treatment. Am J Respir Crit Care Med 1995;152:1170-4.
24. Cheung D, Timmers MG, Zwinderman AH, Be1 EH, Dijkman JH, Sterk PJ. Long-term effects of a long-acting P,-adrenoceptor agonist, salmeterol, on airway hyperresponsiveness in patients with mild asthma. N Engl J Med 1992;327:1198-1203
25. Yates DH, Kharitonov SA, Barnes PJ. An inhaled glucocorticoid does not prevent tolerance to the bronchoprotective effect of a long-acting inhaled beta,-agonist. Am J Respir Crit Care Med 1996;154:1603-7.
26. Tsukagoshi H, Sakamoto T. Xu W. Barnes PJ. Chung KF. Effect of interleukin-lP on airway responsiveness and inflammation in non-sensitised Brown-Norway rats. J Allergy Clin Immunol 1994;93:464-9.
27. Butchers PR, Skidmore IF, Vardey CJ, Wheeldon A. Characterisation of the receptor mediating the antianaphylactic effects of P-adrenoceptor agonists in human lung tissue in vitro. Br J Pharmacol 1980;71:663-7.
28. Peters SP, Schulman ES, Schleimer RP, MacGlashan DWJ, Newball HH, Lichtenstein LM. Dispersed human lung mast cells. Pharmacologic aspects and comparison with human lung tissue fragments. Am Rev Respir Dis 1982;126:1034-9
29. Roberts JA, Bradding P, Walls AF, Holgate PH. The effect of salmeterol xinafoate therapy on lavage findings in asthma [Abstract]. Am Rev Respir Dis 1992;145:A418.
30. Gardiner PV, Ward C, Booth H, Alison A, Hendrick DJ, Walters EH. Effect of eight weeks of treatment with salmeterol on bronchoalveolar lavage inflammatory indices in asthmatics. Am J Respir Crit Care Med 1994;150:1006-11